Commonwealth Equity Services, LLC Novo Nordisk A S Transaction History

Commonwealth Equity Services, LLC

$66 Billion
Q3 2024

A detailed history of Commonwealth Equity Services, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Commonwealth Equity Services, LLC holds 429,333 shares of NVO stock, worth $37.5 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

429,333

Previous 505,992 15.15%

Holding current value

$37.5 Million

Previous $72.2 Million 29.22%

% of portfolio

0.08%

Previous 0.11%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	SELL	$119.07 - $145.42 $9.13 Million - $11.1 Million	-76,659 Reduced 15.15%	429,333 $51.1 Million
Q2 2024 Jul 31, 2024	BUY	$122.71 - $146.91 $11.9 Million - $14.3 Million	97,209 Added 23.78%	505,992 $72.2 Million
Q1 2024 Apr 29, 2024	BUY	$102.11 - $135.92 $17.6 Million - $23.4 Million	172,206 Added 72.79%	408,783 $52.5 Million
Q4 2023 Feb 06, 2024	BUY	$87.78 - $105.45 $3.56 Million - $4.27 Million	40,524 Added 20.67%	236,577 $24.5 Million
Q3 2023 Oct 23, 2023	BUY	$90.94 - $199.54 $9.23 Million - $20.3 Million	101,509 Added 107.37%	196,053 $17.8 Million
Q2 2023 Aug 10, 2023	BUY	$155.98 - $172.65 $1.98 Million - $2.19 Million	12,709 Added 15.53%	94,544 $15.3 Million
Q1 2023 May 11, 2023	BUY	$132.34 - $159.14 $569,856 - $685,256	4,306 Added 5.55%	81,835 $13 Million
Q4 2022 Feb 07, 2023	SELL	$102.55 - $135.33 $57,017 - $75,243	-556 Reduced 0.71%	77,529 $10.5 Million
Q3 2022 Nov 14, 2022	BUY	$95.28 - $116.93 $48,783 - $59,868	512 Added 0.66%	78,085 $7.78 Million
Q2 2022 Jul 19, 2022	SELL	$103.24 - $121.81 $890,754 - $1.05 Million	-8,628 Reduced 10.01%	77,573 $8.64 Million
Q1 2022 May 04, 2022	SELL	$93.1 - $112.54 $105,482 - $127,507	-1,133 Reduced 1.3%	86,201 $9.57 Million
Q4 2021 Jan 31, 2022	SELL	$95.88 - $117.08 $210,552 - $257,107	-2,196 Reduced 2.45%	87,334 $9.78 Million
Q3 2021 Oct 29, 2021	SELL	$84.42 - $106.62 $147,481 - $186,265	-1,747 Reduced 1.91%	89,530 $8.6 Million
Q2 2021 Aug 11, 2021	BUY	$67.66 - $84.76 $53,180 - $66,621	786 Added 0.87%	91,277 $7.65 Million
Q1 2021 May 04, 2021	BUY	$67.06 - $75.82 $370,037 - $418,374	5,518 Added 6.49%	90,491 $6.1 Million
Q4 2020 Feb 11, 2021	BUY	$63.89 - $73.8 $357,784 - $413,280	5,600 Added 7.06%	84,973 $5.94 Million
Q3 2020 Nov 05, 2020	BUY	$63.69 - $70.22 $80,504 - $88,758	1,264 Added 1.62%	79,373 $5.51 Million
Q2 2020 Aug 12, 2020	BUY	$58.54 - $67.94 $55,144 - $63,999	942 Added 1.22%	78,109 $5.11 Million
Q1 2020 May 11, 2020	SELL	$49.46 - $64.78 $240,375 - $314,830	-4,860 Reduced 5.92%	77,167 $4.65 Million
Q4 2019 Feb 05, 2020	BUY	$49.86 - $58.26 $472,373 - $551,955	9,474 Added 13.06%	82,027 $4.75 Million
Q3 2019 Oct 30, 2019	SELL	$47.54 - $53.43 $142,192 - $159,809	-2,991 Reduced 3.96%	72,553 $3.75 Million
Q2 2019 Jul 19, 2019	SELL	$46.79 - $52.47 $1.24 Million - $1.39 Million	-26,547 Reduced 26.0%	75,544 $3.86 Million
Q1 2019 May 13, 2019	BUY	$46.36 - $52.63 $167,962 - $190,678	3,623 Added 3.68%	102,091 $5.34 Million
Q4 2018 Feb 11, 2019	BUY	$41.54 - $47.25 $143,894 - $163,674	3,464 Added 3.65%	98,468 $4.54 Million
Q3 2018 Nov 06, 2018	SELL	$46.76 - $51.24 $21,135 - $23,160	-452 Reduced 0.47%	95,004 $4.48 Million
Q2 2018 Jul 31, 2018	SELL	$44.29 - $50.42 $45,884 - $52,235	-1,036 Reduced 1.07%	95,456 $4.4 Million
Q1 2018 May 14, 2018	SELL	$48.49 - $58.14 $6,934 - $8,314	-143 Reduced 0.15%	96,492 $4.75 Million
Q4 2017 Feb 12, 2018	BUY	$47.53 - $53.73 $4.59 Million - $5.19 Million	96,635	96,635 $5.19 Million

Others Institutions Holding NVO

# of Institutions

1,957

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $197B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Equity Services, LLC with notifications on news.

Account

Commonwealth Equity Services, LLC Novo Nordisk A S Transaction History